Healthcare provider profile · identity verified

Andrew Lay Wiley, D.O.

Internal Medicine · WARREN, MI · NPI 1255652582

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	579	230
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	357	78
Amlodipine Besylate	Amlodipine Besylate	353	137
Lisinopril	Lisinopril	302	117
Albuterol Sulfate Hfa	Albuterol Sulfate	256	117
Levothyroxine Sodium	Levothyroxine Sodium	242	79
Losartan Potassium	Losartan Potassium	213	86
Pantoprazole Sodium	Pantoprazole Sodium	191	70
Famotidine	Famotidine	180	68
Gabapentin	Gabapentin	169	71
Tamsulosin Hcl	Tamsulosin Hcl	153	63
Metoprolol Tartrate	Metoprolol Tartrate	148	59
Atenolol	Atenolol	142	54
Metformin Hcl	Metformin Hcl	134	54
Trazodone Hcl	Trazodone Hcl	132	51
Alendronate Sodium	Alendronate Sodium	124	37
Metformin Hcl Er	Metformin Hcl	119	49
Hydrochlorothiazide	Hydrochlorothiazide	114	50
Simvastatin	Simvastatin	114	40
Escitalopram Oxalate	Escitalopram Oxalate	103	39
Fluticasone Propionate	Fluticasone Propionate	103	44
Furosemide	Furosemide	93	46
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	93	33
Allopurinol	Allopurinol	86	36
Montelukast Sodium	Montelukast Sodium	86	40
Triamcinolone Acetonide	Triamcinolone Acetonide	86	48
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	84	19
Metoprolol Succinate	Metoprolol Succinate	82	28
Alvesco	Ciclesonide	80	35
Glipizide	Glipizide	79	33
Tizanidine Hcl	Tizanidine Hcl	71	30
Clopidogrel	Clopidogrel Bisulfate	68	20
Spiriva Respimat	Tiotropium Bromide	65	24
Prednisone	Prednisone	58	45
Colchicine	Colchicine	57	21
Doxycycline Monohydrate	Doxycycline Monohydrate	57	42
Ozempic	Semaglutide	57	13
Venlafaxine Hcl Er	Venlafaxine Hcl	57	16
Ibuprofen	Ibuprofen	54	31
Sertraline Hcl	Sertraline Hcl	53	18
Ondansetron Hcl	Ondansetron Hcl	52	11
Duloxetine Hcl	Duloxetine Hcl	50	19
Lorazepam	Lorazepam	46	15
Tramadol Hcl	Tramadol Hcl	46	18
Pravastatin Sodium	Pravastatin Sodium	43	18
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	43	14
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	43	12
Hydralazine Hcl	Hydralazine Hcl	41	18
Rosuvastatin Calcium	Rosuvastatin Calcium	41	14
Potassium Chloride	Potassium Chloride	39	14
Nystatin	Nystatin	36	19
Pradaxa	Dabigatran Etexilate Mesylate	36	17
Advair Hfa	Fluticasone Propion/Salmeterol	34	12
Fluoxetine Hcl	Fluoxetine Hcl	34	13
Terazosin Hcl	Terazosin Hcl	34	16
Wixela Inhub	Fluticasone Propion/Salmeterol	34	16
Carvedilol	Carvedilol	33	14
Fluocinonide	Fluocinonide	33	12
Jardiance	Empagliflozin	33	18
Lovastatin	Lovastatin	32	14
Omeprazole	Omeprazole	32	11
Acyclovir	Acyclovir	31	12
Finasteride	Finasteride	31	13
Humulin N	Insulin Nph Human Isophane	31	11
Mirtazapine	Mirtazapine	31	14
Ketoconazole	Ketoconazole	30	13
Hydrocortisone	Hydrocortisone	28	16
Quetiapine Fumarate	Quetiapine Fumarate	28	suppressed
Cefadroxil	Cefadroxil	26	22
Nortriptyline Hcl	Nortriptyline Hcl	26	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	25	23
Fluocinolone Acetonide	Fluocinolone Acetonide	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	25	suppressed
Nabumetone	Nabumetone	25	suppressed
Breyna	Budesonide/Formoterol Fumarate	24	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	24	11
Meloxicam	Meloxicam	24	suppressed
Nitroglycerin	Nitroglycerin	24	12
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Trospium Chloride	Trospium Chloride	24	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Latanoprost	Latanoprost	23	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	18
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	21	12
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Clonazepam	Clonazepam	19	suppressed
Azithromycin	Azithromycin	18	14
Clobetasol Propionate	Clobetasol Propionate	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Pregabalin	Pregabalin	17	suppressed
Spironolactone	Spironolactone	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	16	suppressed
Baclofen	Baclofen	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	15	suppressed
Lactulose	Lactulose	15	suppressed
Mupirocin	Mupirocin	15	11
Veo Insulin Syringe	Syrge-Ndl,ins 0.3 Ml Half Mark	15	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	14	12
Levetiracetam	Levetiracetam	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	12
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Timolol Maleate	Timolol Maleate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Humalog	Insulin Lispro	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed
Ofloxacin	Ofloxacin	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error